Condition: Menstrual Symptoms · Sponsor: Magdy Milad, MD
The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.
This description comes directly from the study's public registry record.
juan A avitia, MS · 312-694-6447 · juan.avitia1@nm.org
Always discuss trial participation with your own doctor first.
| Northwestern University - Northwestern Medicine, Lavin Family Pavilion | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06653426